Hubbry Logo
CementomaCementomaMain
Open search
Cementoma
Community hub
Cementoma
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Cementoma
Cementoma
Cementoma
View on Wikipedia
from Wikipedia
Cementoma
SpecialtyDentistry
Human Tooth Diagram

Cementoma is an odontogenic tumor of cementum. It is usually observed as a benign spherical mass of hard tissue fused to the root of a tooth.[1] It is found most commonly in the mandible in the region of the lower molar teeth, occurring between the ages of 8 and 30 in both sexes with equal frequency .[1] It causes distortion of surrounding areas but is usually a painless growth, at least initially. Considerable thickening of the cementum can often be observed. A periapical form is also recognized. Cementoma is not exclusive to the mandible as it can infrequently occur in the maxilla and other parts of the body such as the long bones.[2]

Signs & Symptoms

[edit]

Cementoma is characterized by a significant amount of thickening of the cementum around the roots of the teeth. The main teeth involved can include deciduous and permanent teeth, impacted molars and premolars.[3] The growth is typically benign and painless. Although symptoms may not be noticeable, a dull pain and dentin hypersensitivity can occur as growth increases. Visibility of the cementoma may increase with growth and cause distortion/swelling to the face and surrounding areas along with tooth displacement.[4] Histological analyses reveal several sheets of cementum that show evidence of both cementoblast and cementoclast activity.[5]

Complications

[edit]

The following complications may occur as a result of growth and expansion in the cementum:[6]

Causes

[edit]

The exact cause of cementomas is still widely unknown. It is understood that cells of the cementum found at the apex of a tooth root in rare cases grow uncontrollably.[4] Cementomas are derived from ectomesenchyme of odontogenic origin.[1][7] Complications of cementogenesis and proliferation of cementoblasts can be implicated; however, cementomas have only been linked to and theorized to be caused by: trauma, reaction to local irritation, infection, endocrine imbalance, cell proliferation and vitamin deficiency.[8]

Pathophysiology

[edit]

Cementomas develop as cells that generate cementum, or cementoblasts uncontrollably proliferate at the apex of a tooth root. Cementoblasts that form the cementum typically cease activity and become cementocytes. However, a layer of cementoblasts lies on the outer layer of the periodontal ligament, in which these cells will resume cementogenic activity upon injury to a tooth.[9] Excessive production of cementum will result in destruction of the periodontal ligament and mandible.[5]

Researchers of a 2017 and 2018 case study, have determined pathogenesis to occurs in three stages. The first stage involves periapical osteolysis which is characterized by a noncalcified matrix and formation of a circular radiolucent area near the apex of the affected tooth.[7][3] The second stage is characterized by active cementoblasts that create radiopaque matter in the center of the lesion. The final stage is characterized by maturation and calcification of the entire lesion in which it is completely radiopaque and surrounded by a radiolucent rim.[3]

Diagnosis

[edit]

A cementoma may present itself on a radiograph or x-ray and appear as an radiopaque mass depending on its stage and mass within the lower dental arch. In early stages, the mass will appear as radiolucent. In terminal stages, the mass becomes radiopaque and a radiolucent rim will be visible.[3] As the lesion enlarges, complexity of diagnosis increases and the mass must be analyzed for characteristics of an odontoma, hypercementosis, cemental dysplasia, and condensing osteitis.[5] Misdiagnosis can result in an unnecessary root canal.

Differential diagnosis

[edit]
  • Cementomas reveal a more uniform radiolucent band surrounding the lesion than the bands found in cement dysplasia.
  • Periapical cemental dysplasia is usually found in the lower anterior teeth and does not cause shifting of teeth.
  • Odontomas have mixed radio density and usually are not continuous into the root.
  • Hypercementosis present with small lesions and are not accompanied by pain or jaw swelling.
  • Condensing osteitis is a well-defined radiopaque lesion usually surrounding the apex of a necrotic tooth and does not have a radiolucent rim.[9]

Prevention/Treatment

[edit]

There are currently no preventative measures available for cementomas. Treatment of a cementoma involves surgically removing the mass and possibly a portion of the affected area and/or teeth. Surgical removal without damage to surrounding teeth is limited unless the lesion is small and if there is a sufficient crown-to-root ratio. Although benign, a cementoma will continue to grow in size if left untreated. Growth will also greatly affect the function of the teeth. If growth and affected teeth are not completely removed, the risk of reoccurrence increases.[4]

Prognosis

[edit]

No malignant form of this conditions exists and rarely will the mass reappear. Individuals can expect full recovery from this condition with the proper treatment and removal of affected area. Although recurrence of cementomas is extremely rare, post-surgical and long-term follow ups are recommended.[3]

Epidemiology

[edit]

Cementoma represent less than one percent of odontogenic tumors.[10] Women and men between their 20s and 30s are most likely to develop a cementoma, with males being slightly more affected than females.[7] Of all cases reported, fifty percent of the patients were under 20 years of age and seventy-five percent were younger than 30 years of age.[4] Occurrence is also seen in both children and older adults. The type of cementoma varies by demographic category.

Research Directions

[edit]

There is a lack of both information and recent research on cementomas. There are multiple individual case studies available on the different types of cementomas, however no clinical trials for treatment of this condition have been executed.[7] A 2018 case report detailed an unusual reoccurrence in a 4.5-year-old boy. The young child was referred to the Oral and Maxillofacial Surgery Department of Tehran University of Medical Sciences and upon examination, they found a well-defined radiopaque mass in the apical region of his right deciduous mandibular second molar. The patient presented with swelling and mild pain, but no difficulty with speech, breathing or swallowing. The first lesion was removed, but at age 5.5, post-surgical follow-ups revealed a new lesion accompanied by mild swelling. This lesion as well as a lesion that appeared at 8 years of age were determined to be a benign cementoma. Each lesion was removed and the boy showed evidence of no further reoccurrence after three post-surgery follow-ups.[3]

Types

[edit]

Four types of cementomas are described:

See also

[edit]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Cementoma

View on Grokipedia
from Grokipedia
Cementoma, historically known as a cementum-producing odontogenic , refers to a group of benign fibro-osseous dysplasias of the jaws that involve the replacement of normal bone with fibrous stroma containing cementum-like calcifications, typically occurring in the tooth-bearing regions around the apices of vital teeth. In contemporary dental pathology, the term is largely synonymous with periapical (PCOD), the most common subtype, which is a non-neoplastic reactive process arising from periodontal ligament fibroblasts and characterized by its nature and self-limiting progression. PCOD predominantly affects middle-aged , with lesions often presenting as multiple, well-circumscribed radiolucencies surrounding the apices of mandibular on radiographs, evolving through stages from purely radiolucent to mixed radiolucent-radiopaque and finally fully radiopaque as calcifications mature. Microscopically, it features irregularly shaped trabeculae of woven or cementoid material embedded in a fibrous stroma, resembling ginger root-like structures, without evidence of . The condition is usually discovered incidentally during routine dental examinations, as it is painless and does not cause or expansion unless secondarily infected. Cemento-osseous dysplasias are classified into three main variants—periapical, focal, and florid—based on the extent and location of involvement, with florid cemento-osseous dysplasia (FCOD) representing a more extensive, multifocal form that can affect multiple quadrants and occasionally lead to complications like due to poor vascularity in the avascular calcified areas. Differential diagnoses include chronic apical periodontitis, ossifying , and fibrous , but the association with vital teeth and lack of cortical expansion distinguish . Management is conservative, involving periodic radiographic monitoring to track progression and prevent unnecessary endodontic intervention, as the lesions do not require surgical removal unless symptomatic. A rare familial variant, gigantiform cementoma, involves expansive, autosomal dominant lesions that can cause facial disfigurement and may necessitate surgical excision.

Clinical Features

Signs and Symptoms

Periapical cemento-osseous dysplasia (PCOD), the most common form of cementoma, is typically and discovered incidentally during routine dental radiographic examinations. Lesions occur around the apices of vital teeth, without causing pain, , or cortical expansion. They predominantly affect the anterior , with a higher prevalence in middle-aged Black women (mean age approximately 40-50 years). In more extensive variants like focal or florid (COD), mild discomfort or swelling may rarely occur if secondarily infected, but uncomplicated cases remain painless. Familial gigantiform cementoma, a rare subtype, can present with progressive expansion starting in or early adulthood, leading to facial asymmetry and potential pain from pressure or fracture.

Complications

Uncomplicated PCOD rarely leads to complications due to its non-expansile nature and association with vital teeth. However, in florid cemento-osseous dysplasia (FCOD), the avascular calcified lesions increase susceptibility to secondary bacterial infection from oral flora, potentially triggered by or trauma. This can result in , suppuration, fistulation, and pain, reported in a subset of symptomatic FCOD cases. Extensive involvement in FCOD or gigantiform cementoma may weaken bone structure, raising the risk of , particularly in familial cases with autosomal dominant . or loss can occur in advanced, infected lesions due to surrounding bone , though root resorption is uncommon in COD. Malignant transformation is exceedingly rare (<1% of cases), with isolated reports of association possibly coincidental rather than causal. Chronic infection in advanced cases may cause functional issues like chewing difficulty or .

Etiology and Pathophysiology

Causes and Risk Factors

The etiology of cementoma, primarily referring to (COD), remains largely unknown, with lesions believed to arise from odontogenic ectomesenchyme, particularly periodontal ligament cells that produce abnormal cementum-like tissue. Recent molecular analyses have identified recurrent hotspot mutations in genes of the RAS-MAPK signaling pathway (including BRAF, , , NRAS, and FGFR3), suggesting a neoplastic component in some cases of COD despite its historical classification as a reactive, non-neoplastic process. Predisposing factors may include local , chronic irritation from occlusal forces, or at the tooth apex, which could initiate reparative responses involving cementoblast proliferation and dysplastic replacement. A higher in middle-aged females, especially those of African descent, points to potential hormonal influences on , though direct causal links remain unestablished. In the rare familial gigantiform variant, genetic factors predominate, with autosomal dominant inheritance confirmed in multiple kindreds and specific heterozygous mutations in the ANO5 gene (e.g., c.1067G>A, p.Cys356Tyr) identified as drivers of multifocal cementum overgrowth. No robust evidence supports a role for environmental carcinogens in cementoma development, given its benign nature; however, isolated case reports have described overlaps with , potentially reflecting shared dysplastic features rather than direct causation.

Disease Mechanisms

Cemento-osseous dysplasia (COD) arises from periodontal ligament fibroblasts in the tooth-bearing areas of the jaws, leading to the replacement of normal with fibro-osseous tissue containing cementum-like calcifications. This is typically reactive and non-neoplastic, though recent genetic findings indicate possible neoplastic elements in some cases. The lesions form around the apices of vital teeth without direct attachment or fusion to the root surface. The development of progresses through distinct stages, beginning with an initial radiolucent phase due to localized osteolysis and fibrous proliferation. This is followed by a mixed phase with deposition of cementoid and woven matrix by activated fibroblasts, transitioning to a mature radiopaque stage as calcifications accumulate, often with a thin radiolucent rim representing the periodontal . In the periodontal ligament and adjacent bone, COD induces gradual replacement of normal tissues with the expanding fibro-osseous lesion, which remains confined without invasive growth into surrounding structures. This behavior underscores its benign, self-limiting nature, primarily affecting the apical regions and exhibiting no metastatic potential. Histologically, COD is composed of irregularly shaped trabeculae of woven or cementoid material embedded in a moderately cellular fibrous stroma, often resembling ginger root-like structures. The calcified areas show haphazard mineralization with cementum-like spherules, without evidence of cellular or .

Diagnosis

Clinical Evaluation

Clinical evaluation of cementoma begins with a detailed history. The condition is typically and discovered incidentally during routine dental examinations. Inquiry into family history may be relevant for rare familial variants like gigantiform cementoma. During the physical examination, there is usually no palpable tenderness, swelling, or facial asymmetry, as the lesions do not cause expansion unless secondarily infected. Inspection of the alveolar ridge reveals no significant changes, and is absent in uncomplicated cases. These findings, combined with demographic correlations, raise suspicion for cementoma. Demographic correlations guide the evaluation, with cementoma predominantly affecting middle-aged . The lesions most frequently involve the apices of mandibular . Vital pulp testing confirms tooth vitality, which is preserved in all cases.

Imaging and Histopathology

Imaging of cementoma, also known as , primarily relies on conventional to identify its characteristic evolution through developmental stages. In the early osteolytic phase, the lesion appears as a well-circumscribed radiolucent area at the apex of vital , typically measuring less than 1 cm in diameter and lacking expansion. As it progresses to the intermediate stage, radiographic findings show a mixed radiolucent-radiopaque pattern with nodular calcifications, often demonstrating involvement of the root on panoramic radiographs. In the mature calcified phase, the lesion becomes predominantly radiopaque with a thin surrounding radiolucent rim, reflecting the dense sclerotic cementum-like material, and may involve multiple without root resorption. These stages correlate with pathophysiological progression from osteolytic resorption to cementum deposition, aiding in non-invasive staging. Advanced imaging modalities enhance diagnostic precision, particularly for assessing lesion extent and complications. Cone-beam computed tomography (CBCT) provides three-dimensional visualization, revealing the lesion's precise location, involvement of surrounding structures like the cortical plates, and any root involvement or perforation, which is crucial for subtypes like periapical or focal cementoma. (MRI) is infrequently required but can differentiate components or associated if the lesion exhibits atypical expansion or secondary . Histopathological confirmation via is reserved for atypical presentations to rule out mimics, as routine risks infection in avascular mature lesions and is generally not required given the characteristic radiographic features. Microscopically, early lesions feature a cellular fibrous stroma with small, droplet-like calcifications resembling immature or woven . Mature specimens show hypocellular, avascular sclerotic masses of cementum-like material with curvilinear trabeculae, cementicles, and occasional reversal lines, lacking plump cementoblasts or mitoses. The diagnosis relies on integration of these findings with clinical and radiographic correlation. The (WHO) criteria classify cementoma into periapical, focal, and florid subtypes based on location and extent, emphasizing its non-neoplastic fibro-osseous nature without odontogenic epithelium.

Differential Diagnosis

Cementoma must be differentiated from other radiopaque or mixed-density jaw lesions that may present with periapical involvement. Key benign differentials include chronic apical periodontitis, which is associated with nonvital teeth and lacks calcifications. Ossifying fibroma is distinguished by its more expansive growth and lack of association with vital teeth apices. Fibrous dysplasia features ground-glass radiopacities and cortical expansion, often affecting larger areas. Malignant mimics such as require exclusion, as it shows aggressive features like cortical destruction and ill-defined borders on imaging, unlike the well-circumscribed nature of cementoma. Periapical or presents as purely radiolucent lesions tied to nonvital teeth. Diagnostic clues include the lesion's association with vital teeth without cortical expansion and the presence of a radiolucent rim surrounding radiopacities on radiographs in later stages. For atypical cases, reveals irregularly shaped trabeculae of woven bone or cementoid material in fibrous stroma, distinguishing it from other fibro-osseous lesions.

Management

Treatment Approaches

The primary treatment for benign cementoblastoma, a neoplastic variant of cementoma, in symptomatic cases involves surgical enucleation and to remove the lesion completely; extraction of the affected tooth is traditionally performed if it is fused to the lesion, though conservative tooth-preserving approaches with endodontic are possible in select cases. In instances where the pulp is involved, endodontic may be performed prior to or in conjunction with surgical intervention, such as followed by , allowing tooth preservation in select cases. For symptomatic variants of (COD), such as florid COD with infection or expansion, enucleation under local or general may be recommended, with of the site using saline and local antibiotics during the procedure. Asymptomatic cementomas, including most cases of periapical , are managed conservatively through regular clinical monitoring and serial radiographic imaging to track lesion stability and detect any progression. This approach avoids unnecessary intervention, as the condition is typically self-limiting and extraction is discouraged due to risks of poor in avascular . Postoperative care for surgical cases emphasizes infection prevention with systemic antibiotics, such as amoxicillin at 1 g every 12 hours for 7-10 days, alongside rinses, and scheduled follow-up radiographs at 6-12 months to assess and recurrence. Challenges in treatment for neoplastic types like benign include ensuring complete lesion excision to minimize recurrence rates, which can reach approximately 32% if residual tissue remains; a multidisciplinary collaboration between oral surgeons, endodontists, and radiologists is recommended for optimal outcomes. For non-neoplastic , recurrence is rare following conservative management.

Prevention Strategies

The of most cementomas, particularly , is unknown, so specific preventive measures for development are not established. However, maintaining good practices, such as regular brushing, flossing, and professional cleanings, is essential to reduce the risk of secondary infections or complications in existing lesions. Routine dental check-ups facilitate early detection of potential lesions or associated issues, allowing for timely monitoring to prevent progression. Early treatment of periapical infections, including prompt management of dental caries and pulp , helps prevent complications in susceptible individuals with or at risk for cementoma. For familial gigantiform cementoma, genetic screening in affected families is recommended, particularly testing for mutations in the ANO5 gene, to identify at-risk individuals and enable proactive monitoring. This approach supports early surveillance without curative intent but aids in managing familial patterns.

Prognosis and Epidemiology

Clinical Outcomes

Cemento-osseous dysplasias (COD), the primary form of cementoma, generally exhibit an excellent prognosis due to their benign, non-neoplastic nature. Most cases are asymptomatic and self-limiting, requiring only periodic clinical and radiographic monitoring, with stabilization occurring without intervention in the vast majority of patients. Surgical intervention is rarely indicated and is reserved for symptomatic cases, such as secondary infection in the florid variant, where conservative management including antibiotics and sequestration removal may be necessary to prevent complications like . The expansile familial gigantiform variant may require surgical excision in advanced cases to address disfigurement, but recurrence is uncommon following complete removal. COD lesions do not typically recur, as they represent a reactive process rather than a ; however, symptomatic exacerbations can occur in poorly vascularized areas if infected, emphasizing the importance of avoiding unnecessary invasive procedures. Patients usually maintain normal function and with monitoring alone, though extensive florid or gigantiform lesions may occasionally necessitate prosthetic rehabilitation for aesthetics and function.

Demographic Patterns

Cemento-osseous dysplasia (COD) is relatively common in certain populations, with a reported age-adjusted prevalence of approximately 5.5% among Black females. It predominantly affects females, with ratios ranging from 87% to 96% across studies, and shows a peak incidence in the fourth and fifth decades of life, with mean ages at diagnosis around 48-58 years. The condition has a higher prevalence in individuals of African and Asian descent, though it occurs across ethnicities; mandibular involvement is more frequent, particularly in anterior regions for periapical COD and multifocal in florid COD. Geographically, reporting may be higher in regions with advanced dental imaging access, potentially underrepresenting incidence in underserved areas. Familial cases are rare but noted in the gigantiform variant, with around 40 families documented globally, often presenting at younger ages.

Classification

Overview of Types

The term "cementoma" is historical, originating in the late to describe various cementum-producing proliferations in the jaws, and was broadly applied for over a century to encompass both neoplastic and non-neoplastic fibro-osseous lesions of odontogenic origin. In the (WHO) classification of head and neck tumors, specific entities derived from periodontal ligament cells capable of forming cementum-like tissue are categorized separately: benign cementoblastoma as a benign odontogenic tumor, and cemento-osseous dysplasias as non-neoplastic fibro-osseous lesions. The 2022 WHO update refines this framework by incorporating familial variants and clarifying distinctions between true neoplasms and reactive or developmental processes. Cemento-osseous dysplasia (COD) is classified into three main subtypes based on extent and location: periapical (most common, at apices of vital anterior mandibular teeth), focal (solitary lesions often in posterior or edentulous areas), and florid (multifocal, involving multiple quadrants). The 2022 update added a fourth subtype, familial florid COD, an inherited form with expansive lesions. Other related entities include benign (typically solitary, fused to tooth roots), familial gigantiform (a rare, expansive familial variant sometimes synonymous with or related to familial florid COD), and (a central fibro-osseous ). These categories reflect variations in clinical behavior, radiographic appearance, and histological composition, unified by aberrant deposition. By the mid-20th century, classifications evolved to separate true neoplasms like from dysplastic processes such as , with the 1971 WHO edition formalizing "benign cementoblastoma" while the 2022 update highlights ectomesenchymal origins and recognizes familial gigantiform cementoma within the dysplasia spectrum. A key distinguishing feature among these lesions is their relationship to tooth : entities like benign and periapical are typically fused or adjacent to root apices, reflecting periodontal derivation, whereas cemento-ossifying and familial gigantiform cementoma often show independent intraosseous growth, potentially leading to expansion without direct root attachment. This spatial variation aids in preliminary radiographic differentiation.

Key Variants

Benign cementoblastoma is a rare odontogenic tumor that typically arises from the of , most commonly affecting the posterior , such as the first molar, in young adults with a mean age of around 20 years and a slight male predominance. Clinically, it presents as a slow-growing, often painful mass associated with a vital , leading to swelling and potential root resorption, though it may remain in some cases. Radiographically, it appears as a well-defined radiopaque or mixed-density mass fused to the , often exhibiting a pattern and encircled by a thin radiolucent rim, with loss of the periodontal ligament space. Management involves complete surgical enucleation of the lesion along with extraction of the involved to prevent recurrence, which can reach up to 37% with incomplete removal. Periapical cemento-osseous dysplasia (PCOD), a subtype of , is a benign fibro-osseous that commonly occurs multifocally at the apices of vital mandibular , predominantly affecting females with a mean age of around 49 years. It is typically and discovered incidentally on routine dental radiographs, though larger lesions or those complicated by secondary may cause , swelling, or discomfort. Radiographically, early stages show well-defined radiolucent areas at the tooth apices, progressing to mixed radiolucent-opaque and eventually fully radiopaque lesions without root resorption or cortical expansion. As a self-limiting condition, for cases emphasizes observation with periodic radiographic follow-up and good to avoid complications like ; surgical intervention is reserved for symptomatic lesions and involves with antibiotics, showing no reported recurrences post-treatment. Familial gigantiform cementoma (FGC), also known as familial florid cemento-osseous dysplasia in the 2022 WHO classification, is a rare, inherited fibro-osseous lesion characterized by massive, multifocal expansion of the and , often beginning in adolescence around ages 11-13 and causing significant facial disfigurement, , and . It follows an autosomal dominant inheritance pattern, with diffuse radio-opaque masses on imaging leading to cortical thinning and potential long bone involvement, such as osteopenia and fractures. Clinically benign but aggressive in growth, it suppresses by early adulthood but requires aggressive surgical management, including extensive resection (e.g., mandibulectomy) and reconstruction, supplemented by calcium and to address bone mineral density issues; no recurrences have been noted in followed cases. Cemento-ossifying fibroma, previously termed cementifying fibroma, is a slow-growing, benign fibro-osseous originating from the periodontal , primarily affecting the in young to middle-aged adults and presenting as a painless, expansile central that may cause facial asymmetry if untreated. Histologically, it features a fibrous stroma with variable amounts of cementum-like calcifications and bone, distinguishing it by its more prominent fibrotic component compared to cementum-dominant lesions. Radiographically, it appears as a well-circumscribed, mixed radiolucent-radiopaque with possible divergence but no attachment to teeth. Treatment consists of en bloc surgical resection or enucleation with for smaller lesions to ensure complete removal and minimize recurrence, particularly in the more aggressive juvenile variant.

Research Directions

Current Studies

Recent case reports from 2017 to 2023 document rare recurrences of , a subtype of cementoma, in pediatric and adolescent patients following surgical excision. In one instance, a 16-year-old developed recurrent benign in the mandibular molar region several months after initial treatment involving removal and extraction, highlighting the challenges in achieving complete resection to prevent regrowth. Such cases remain infrequent, with overall recurrence rates for reported at 11.8% to 37%, often linked to incomplete margins. These reports emphasize the role of cone-beam computed tomography (CBCT) in preoperative planning to define precise surgical margins and reduce recurrence risk. CBCT provides three-dimensional visualization superior to traditional radiographs, enabling accurate assessment of lesion extent and attachment to tooth roots, which is critical for conservative or en bloc resection strategies in young patients. Genetic investigations into gigantiform cementoma, a rare familial variant, have identified heterozygous mutations in the ANO5 gene, particularly the recurrent p.Cys356Tyr variant, through analysis of affected kindreds. Limited cohort studies, including one involving three patients from a single family, confirm these mutations' association with expansive lesions and suggest autosomal dominant patterns, though larger pedigrees are needed for validation. Histological advancements feature immunohistochemical markers such as to differentiate cementoma variants from similar fibro-osseous lesions. In cementoblastoma specimens, cementoblast-like cells exhibit strong osteocalcin positivity, aiding in confirming cementum production and distinguishing from ossifying fibromas, as demonstrated in recent case analyses. Epidemiological updates from 2022 to 2025 reveal a slight increase in reported periapical (PCOD) cases, likely attributable to enhanced detection via advanced imaging like CBCT. A 2024 retrospective review of panoramic radiographs identified COD findings, including PCOD, in 1.0% of cases, surpassing earlier estimates. Similarly, a 2025 multi-center study reported PCOD comprising 8.2% of COD diagnoses, reflecting improved radiographic sensitivity in diverse populations.

Emerging Therapies

Recent investigations into targeted therapies for dysplastic variants of cementoma, such as (COD), have explored inhibitors like to potentially halt excessive production by modulating activity. In a 2025 , off-label (60 mg every 3 months) was administered to a 45-year-old with atypical florid COD affecting the entire , resulting in rapid of osteolytic lesions and disease stabilization after 9 months, as confirmed by , without progression or need for surgical resection. Bisphosphonates, while potent inhibitors of , are generally avoided in COD due to heightened risk of , as evidenced by multiple reports of adverse outcomes in affected s. Minimally invasive approaches, including laser-assisted lesion removal and , are under consideration for early-stage cementoma to preserve tooth structure, particularly when lesions mimic periapical pathology in vital teeth. Although specific trials for cementoma are absent, regenerative endodontic procedures have shown efficacy in resolving associated inflammatory lesions in immature teeth with similar fibro-osseous involvement, promoting pulp-dentin regeneration and avoiding extraction. Laser-assisted disinfection has been integrated into regenerative protocols to enhance outcomes in endodontic cases, potentially adaptable for cementoma's early dysplastic phases to minimize invasive surgery. For familial gigantiform cementoma (FGC), and screening have advanced with the identification of recurrent heterozygous mutations in the ANO5 gene, such as c.1067G>A (p.Cys356Tyr), observed in multiple affected families and linked to early-onset multi-quadrant lesions. These findings support ANO5 testing as an auxiliary diagnostic tool, enabling proactive family screening, though no CRISPR-based models or clinical trials for gene editing exist as of 2025. Key research gaps include the need for large-scale epidemiological studies to better delineate and FGC progression, as current analyses are limited to cohorts like 191 cases primarily affecting females in their fourth decade. Long-term outcome registries are essential to track treatment responses, while potential reclassification of cementoma may occur in future WHO updates beyond the 2022 odontogenic lesions framework, emphasizing fibro-osseous disorders.

References

  1. https://pmc.ncbi.nlm.nih.gov/articles/PMC10293505/
  2. https://www.pathologyoutlines.com/topic/mandiblemaxillafloridcemento.html
  3. https://bmcoralhealth.biomedcentral.com/articles/10.1186/s12903-019-0843-0
  4. https://omim.org/entry/137575
  5. https://www.pathologyoutlines.com/topic/mandiblemaxillaperiapicalcementoosseous.html
  6. https://pmc.ncbi.nlm.nih.gov/articles/PMC9065647/
  7. https://pmc.ncbi.nlm.nih.gov/articles/PMC7021850/
  8. https://www.nature.com/articles/srep26440
  9. https://radiopaedia.org/articles/cemento-osseous-dysplasia?lang=us
  10. https://link.springer.com/article/10.1007/s11282-024-00758-2
  11. https://doi.org/10.3390/dj11050138
  12. https://pubmed.ncbi.nlm.nih.gov/9615352/
  13. https://pmc.ncbi.nlm.nih.gov/articles/PMC11000969/
  14. https://pmc.ncbi.nlm.nih.gov/articles/PMC8083436/
  15. https://pmc.ncbi.nlm.nih.gov/articles/PMC10729712/
  16. https://pmc.ncbi.nlm.nih.gov/articles/PMC10217321/
  17. https://pmc.ncbi.nlm.nih.gov/articles/PMC5018628/
  18. https://pmc.ncbi.nlm.nih.gov/articles/PMC5923893/
  19. https://www.joms.org/article/S0278-2391(16)30386-X/abstract
  20. https://pubmed.ncbi.nlm.nih.gov/35491138/
  21. https://pubmed.ncbi.nlm.nih.gov/37649308/
  22. https://pmc.ncbi.nlm.nih.gov/articles/PMC11594457/
  23. https://www.cureus.com/articles/203316-cemento-osseous-dysplasia-a-detailed-comparison-of-the-2005-and-2017-who-classifications-and-case-analysis
  24. https://www.pathologyoutlines.com/topic/mandiblemaxillawhoclassification.html
  25. https://pmc.ncbi.nlm.nih.gov/articles/PMC9019005/
  26. https://pmc.ncbi.nlm.nih.gov/articles/PMC9999699/
  27. https://pmc.ncbi.nlm.nih.gov/articles/PMC10767285/
  28. https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/606812
  29. https://pmc.ncbi.nlm.nih.gov/articles/PMC3227271/
  30. https://radiopaedia.org/articles/cementoblastoma?lang=us
  31. https://www.mdpi.com/2304-6767/11/5/138
  32. https://www.pathologyoutlines.com/topic/mandiblemaxillaossifyingfibroma.html
  33. https://www.semanticscholar.org/paper/Recurrent-benign-cementoblastoma%253A-A-case-report-and-Yoon-Kwon/e3bea8c57533235d6b0500013792319f4b938e48
  34. https://www.sciencedirect.com/science/article/pii/S193004332400116X
  35. https://pmc.ncbi.nlm.nih.gov/articles/PMC8171136/
  36. https://pmc.ncbi.nlm.nih.gov/articles/PMC8715555/
  37. https://onlinelibrary.wiley.com/doi/full/10.1002/mgg3.2277
  38. https://www.researchgate.net/publication/244943034_Expression_of_Ki67_Osteocalcin_and_Ostepontin_in_Cementoblastoma
  39. https://onlinelibrary.wiley.com/doi/abs/10.1002/osi2.1234
  40. https://pmc.ncbi.nlm.nih.gov/articles/PMC12058939/
  41. https://bmcoralhealth.biomedcentral.com/articles/10.1186/s12903-025-05514-4
  42. https://www.journalomp.org/journal/view.html?doi=10.14476/jomp.2021.46.2.49
  43. https://pmc.ncbi.nlm.nih.gov/articles/PMC9712432/
  44. https://pmc.ncbi.nlm.nih.gov/articles/PMC11033860/
Add your contribution
Related Hubs
User Avatar
No comments yet.